3D transparent human heart highlighting kidneys in red, promoting a call for papers on incretin-based cardiovascular disease strategies.
Hey attendees of #DiabetesCanada and #CSEM_SCEM conference. #CJPPjournal publishes your research on the effects of #IncretinTherapy on the #Heart. ❤️
See our #CallForPapers for our new GLP-1, GIP, and the Heart collection: https://ow.ly/tX1A50XylQL
#DiabetesAwarenessMonth
Innovent’s Mazdutide injection packaging and pens in 2 mg, 4 mg, and 6 mg doses, shown with labeled boxes and corresponding injection pens for type 2 diabetes and obesity treatment.
Innovent’s mazdutide outperformed semaglutide in a key Phase 3 trial for type 2 diabetes and obesity. Expert commentary highlights trial design, metabolic mechanisms and next-gen incretin therapy questions.
jcst2d.com/index.php/ne...
#Mazdutide #Semaglutide #T2D #Obesity #IncretinTherapy
